Dec 17, 2004 | NEWS
Reykjavik, ICELAND, December 17, 2004 – deCODE genetics (Nasdaq: DCGN) today announced the signing of an agreement under which it will conduct a Phase II information-rich clinical trial next year of a third-party compound as part of a drug development program in...
Dec 4, 2004 | NEWS
December 4, 2004 A deCODE study just published in Public Library of Science (PloS) Medicine provides the most comprehensive analyses to date of the importance of inherited risk factors for the most common forms of cancer. The results indicate that increased risk of...
Oct 19, 2004 | NEWS
• Study achieves primary endpoints; DG031 shown to be well-tolerated and to significantly reduce levels of leukotriene B4 and myeloperoxidase • First ever clinical trial based upon the isolation of a disease gene in a common disease Reykjavik, ICELAND, October 19,...
Oct 3, 2004 | NEWS
October 3, 2004 October 3, 2004 – In a paper published today in the online edition of Nature Genetics, a deCODE-led team of scientists present the results of a large-scale population study linking recombination rate with maternal age and fertility. In the paper,...
Jun 18, 2004 | NEWS
Study to conclude in late August; data will be used in the design of an information-rich Phase III study for the prevention of heart attack Reykjavik, ICELAND, June 18, 2004 ― deCODE genetics (Nasdaq:DCGN) today announced the completion of enrollment for its ten-week,...
Feb 6, 2004 | NEWS
February 6, 2004 Gene encoding FLAP also confers risk for stroke; discovery pinpoints common biological mechanism underlying two of the world’s biggest public health challenges In a paper published in the online edition of Nature Genetics, a deCODE-led team of...
